搜尋結果
Eli Lilly’s weight loss drug Zepbound shows promise as a sleep apnea treatment in late-stage trials
CNBC· 3 日前An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City, U.S., December ...
The Three Body Problem, Natural “Laws” and Sustainability
Forbes· 3 日前A science fiction novel by Hugo-award winning writer Liu Cixin has transcended geopolitics and ...
Council Post: Balancing The Cost Of AI In Healthcare: Future Savings Vs. Current Spending
Forbes· 3 日前The big question for healthcare leaders is whether to start using AI now or wait. Here, ...
Fintech Takes Pole Position Again As U.K. Startup Funding “Stabilizes”
Forbes· 3 日前In the first quarter of 2024, British startups attracted investment of $3.9 billion, down from ...
Rethinking Emerging Risks For 2024
Forbes· 3 日前... business risks reported by corporate directors and officers globally for 2024, with ... ...
Hong Kong stocks gyrate as Fed chair Powell strikes hawkish tone on inflation
South China Morning Post· 3 日前Hang Seng Index hovers near a five-week low after comments by Fed chairman Jerome Powell, who said it could take ‘longer ...
Rio Tinto aims to keep Resolution's copper in US, executive says
Reuters· 3 日前, opens new tab aims to keep all of the copper from its Resolution mine inside the United States should the long-delayed ...
US stocks end mixed on rising Treasury yields, Middle East jitters
Reuters· 3 日前Wall Street see-sawed to a mixed close on Tuesday as rising U.S. Treasury yields and elevated ...
What Does Generative AI-Ready Look Like for Finance?
The Wall Street Journal· 3 日前Generative AI’s emergence represents the culmination of two technological breakthroughs. One is ...
Decarbonizing Steel Production: More Than a Pipe Dream
The Wall Street Journal· 3 日前... the commercialization of new, lower-carbon technologies for making iron, combined with ... ...